N-[(1H-benzimidazol-2-yl)(phenyl)methyl]-2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)acetamide
Chemical Structure Depiction of
N-[(1H-benzimidazol-2-yl)(phenyl)methyl]-2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)acetamide
N-[(1H-benzimidazol-2-yl)(phenyl)methyl]-2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)acetamide
Compound characteristics
Compound ID: | Y043-5862 |
Compound Name: | N-[(1H-benzimidazol-2-yl)(phenyl)methyl]-2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)acetamide |
Molecular Weight: | 439.47 |
Molecular Formula: | C25 H21 N5 O3 |
Smiles: | C(C1C(Nc2ccccc2C(N1)=O)=O)C(NC(c1ccccc1)c1nc2ccccc2[nH]1)=O |
Stereo: | MIXTURE OF STEREOISOMERS |
logP: | 2.6494 |
logD: | 2.6368 |
logSw: | -3.5451 |
Hydrogen bond acceptors count: | 7 |
Hydrogen bond donors count: | 4 |
Polar surface area: | 93.794 |
InChI Key: | IEYWBEROUPQPII-UHFFFAOYSA-N |